Physician Access Strategy: Reaching No-See and Low-Access Prescribers
How pharma plans for physicians who limit rep visits: measuring access, choosing channels, using media and inside sales, and working with field teams.
The short answer
A physician access strategy is a plan for reaching prescribers who limit or refuse sales rep visits. It starts by measuring access for each HCP, then assigns the right mix of remote reps, email, endemic and programmatic media, point of care, and medical education. Media carries more of the load for low-access HCPs, so it should be planned and measured against that specific group rather than the whole list.
Many physicians now limit rep visits, and many health systems restrict them by policy. For brands built around field promotion, that leaves a large part of the target list hard to reach. A physician access strategy treats this as a planning input, not an afterthought.
Step 1: Measure access
Classify each target HCP into one of three groups:
- Full access. Regular in-person visits.
- Limited access. Occasional visits, lunch-only, appointment-only, or virtual only.
- No access. No rep contact.
Sources include CRM call outcomes, rep-entered access codes, and system-level policies. Refresh it often. Access shifts when a practice joins a health system.
Step 2: Understand why
Access is restricted for different reasons, and each suggests a different approach:
| Reason | What tends to work |
|---|---|
| Health system policy | HCO engagement, pharmacy and committee channels, point of care |
| Time pressure | Short email, remote reps on HCP schedule, point of care |
| Preference for independent information | Medical education, peer content, endemic clinical sites |
| Low relevance of the brand | Better targeting, or deprioritize |
Step 3: Assign channels
For limited and no-access HCPs, the mix shifts:
- Remote and inside sales. Scheduled virtual calls, often better accepted than visits.
- Email. Requires opt-in or a rented list that reaches them. See HCP email marketing.
- NPI-matched programmatic and endemic. Reach and reminders at scale.
- Point of care and EHR. Messages near the decision. See point-of-care marketing.
- Medical education and webinars. Depth without a rep in the room.
- Peer programs. Within company policy and compliance rules.
Step 4: Budget media to the gap
A common mistake is spreading media evenly across the list. If field covers full-access HCPs well, extra media there adds frequency, not reach. Shift weight to limited and no-access groups, especially high-tier ones.
Hypothetical example. A brand has 15,000 target HCPs. 6,000 are full access, 5,000 limited, and 4,000 no access. Instead of buying equal impressions for all 15,000, the plan sets a higher reach and frequency goal for the 9,000 limited and no-access HCPs, and a light reminder level for the full-access group.
Step 5: Measure on the right group
Report reach, engagement, and prescribing impact separately for each access group. If media cannot be shown to work for no-access HCPs, the strategy has a gap no amount of field effort will fill. The coordination guide explains how to align reporting across channels.
Coordination with field
- Share media exposure and engagement data with reps for limited-access HCPs, so they can follow up when they do get time.
- Avoid sending reps to no-access HCPs because media showed engagement. That can damage relationships.
- Agree on who "owns" each HCP's next action.
Common mistakes
- Using national averages for access instead of measuring your list.
- Treating access as permanent.
- Measuring media across the whole list, which hides how it performs where it matters most.
- Assuming no-access HCPs are low value. Many are high prescribers.
Practical takeaway
Split your target list by access level and look at reach by group for last quarter. If the no-access high-tier HCPs had the lowest reach, the media plan is reinforcing the field gap instead of filling it.
Frequently asked questions
What is a no-see physician?
A physician who does not meet with pharmaceutical sales representatives, either by personal choice or because their practice or health system restricts access.
How do you measure HCP access?
Most brands use field call data: attempted versus completed calls, plus access codes reps record. Some add third-party access data. Classify HCPs as full, limited, or no access.
Can media replace sales reps?
Not fully. Media is good at reach and reminders but cannot hold a two-way conversation. For low-access HCPs, media, remote reps, email, and medical education together fill the gap.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.